From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
about
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomesTraining HIV physicians to prescribe buprenorphine for opioid dependence.Long term Suboxone™ emotional reactivity as measured by automatic detection in speech.Correlates of illicit methadone use in New York City: a cross-sectional study.Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?Pharmacological maintenance treatments of opiate addiction.Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Buprenorphine for opioid dependenceAttenuation of morphine withdrawal signs, blood cortisol and glucose level with forced exercise in comparison with clonidineThe history of the development of buprenorphine as an addiction therapeutic.A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans.Barriers to drug treatment for IDU couples: the need for couple-based approachesPatient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adoptersOligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancyThe "new masculinity": addiction treatment as a reconstruction of gender in Puerto Rican evangelist street ministriesAfrican American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patientsLong-term outcomes of office-based buprenorphine/naloxone maintenance therapy.The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clustersThe Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level AnalysisPharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence.Financial factors and the implementation of medications for treating opioid use disorders.To Be Free and Normal: Addiction, Governance, and the Therapeutics of BuprenorphineA randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African AmericansState policy influence on the early diffusion of buprenorphine in community treatment programsUses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.Buprenorphine/Naloxone Maintenance Therapy: an Observational Retrospective Report on the Effect of Dose on 18 months Retention in an Office-Based Treatment Program.Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013.Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities.Gender differences in heroin users receiving methadone maintenance therapy in Taiwan.
P2860
Q28082657-4DA63188-6AA3-4B17-AC1C-E117C28DC5C3Q30230238-43A6E326-1981-4F1E-91E7-A75803B55DA9Q30452109-5DA6D7EC-B797-4D42-86A7-ADC6F581AD02Q33379960-CCD07617-0794-4A37-973E-A0335013CB50Q33582068-3F57AD0A-B9E1-44C7-8938-FDAD4A4B11E5Q33582080-01BDC1D9-69DA-4C09-9CE5-41A8519E4353Q33625968-FF155D25-93F3-4861-9AF6-5E945890C53FQ33688813-90C8E869-9268-433F-BEEB-88542B97A83FQ34081656-40F5FCB1-6419-4B50-9738-A55BC63C1255Q34119459-8EEC599C-B68B-4B41-9BA4-8B59D6836855Q34197129-E5A1CEB4-6532-4777-8DF1-75669DC4D046Q34248057-C3133566-5F69-4561-BBBA-158ED0A22F48Q34253036-2FC45F28-8BA4-4B26-975A-60854D8DECA1Q34314041-0F346214-1520-43C0-A457-9A8A19817A50Q34376330-A76D3D4C-3E80-490D-932F-58A3A5336BFEQ34432627-ED350980-1055-455B-A351-AE1DFC37DCB9Q35199231-54D2102E-AD49-46D9-A9F7-73DF29B05E45Q35552420-23E1EDCD-8544-47DC-8F4B-D9CD69079D54Q35621885-6705A5B4-E435-4E60-9E84-0677CC7FEC56Q35653149-29CA15F9-94A9-421D-8EAE-48CEF46B5277Q35687716-31FA67E8-8D03-4C0C-B2B9-D538AF0741E9Q35792939-186C5711-A78C-4FB4-B63A-E69B8275D242Q35828982-D1D6CAFE-CBB6-478A-88BA-04A1F154D6CDQ36248583-4F392250-5707-42D6-9176-462CFC780668Q36381418-B3954214-C556-4411-B398-F7F714C36506Q36399916-B9D8C262-1B2C-4322-A3AE-E979B9600F1AQ36579283-CBF94E5B-E70D-4AE9-92E1-4A32B790031DQ36766544-CC4CFBB0-CB81-4C60-8F72-348A4ECB4F65Q37407584-E0B2ED44-C598-476E-B924-A6D65F93FFDAQ37587221-ACEB0724-622D-45B2-AAD7-2A208C4762B6Q38602295-93959885-1F8C-4E3F-A297-D02E9571D58DQ38719155-A2E3BDF3-9019-46EB-B32D-E20945601E89Q40142815-C8357BFF-A74C-49DB-861A-30AF1B8F641EQ42375619-E241EC3A-9982-4D13-BFF1-49E1A0BD6906Q43584958-0D84A110-A294-4923-A260-4D992E94708BQ46964805-066415C7-335C-49B4-B78E-2AD9F1E4A7AEQ47561425-29A0BE3F-3335-4FEC-A7A4-BA739B3B481AQ51228432-E9D8B07D-59E7-4F84-A44F-7257ED1825F0
P2860
From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
From morphine clinics to bupre ...... ddiction in the United States.
@ast
From morphine clinics to bupre ...... ddiction in the United States.
@en
type
label
From morphine clinics to bupre ...... ddiction in the United States.
@ast
From morphine clinics to bupre ...... ddiction in the United States.
@en
prefLabel
From morphine clinics to bupre ...... ddiction in the United States.
@ast
From morphine clinics to bupre ...... ddiction in the United States.
@en
P1476
From morphine clinics to bupre ...... ddiction in the United States.
@en
P2093
Charles O'Keeffe
Jerome H Jaffe
P356
10.1016/S0376-8716(03)00055-3
P433
P577
2003-05-01T00:00:00Z